Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer

Christopher D'Avella, J. Nicholas Bodor

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Article numbere2132860
Pages (from-to)e2132860
JournalJAMA network open
Volume4
Issue number11
DOIs
StatePublished - Nov 4 2021

Keywords

  • Carcinoma, Non-Small-Cell Lung/diagnosis
  • ErbB Receptors/genetics
  • Humans
  • Lung Neoplasms/diagnosis
  • Neoplasm Staging

Fingerprint

Dive into the research topics of 'Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this